Periodic Reporting for period 1 - TS4NC (TS4NC: Therapeutic S4N Chelation targeting Alzheimer's Disease.)

Despite enormous research efforts across academia and pharmaceutical industry, all clinical trials over the last decade have failed in finding a treatment for Alzheimer’s Disease (AD) which remains one of the greatest challenges in drug discovery. This neurodegenerative...